Abstract
Aim The present study sought insight into the effects of remifentanyl and fentanyl on LPS-induced release of interleukin-6 (IL-6), tumor necrosis factor-α (TNF-α) and IL-10 in human whole blood. Methods Whole blood was incubated in the presence and absence of remifentanyl and fentanyl. Effects of remifentanyl and fentanyl on spontaneous and endotoxin (lipopolysaccharide; 100 ng ml−1)-stimulated cytokine release were studied in whole blood from volunteers (n = 10) cultured for 6 h. Results IL-6, TNF-α and IL-10 concentrations in groups added with LPS were significantly higher than those in control group (P < 0.01). IL-6, TNF-α and IL-10 concentrations in activation groups treated with remifentanyl or fentanyl were significantly lower than those in LPS treated group (P < 0.05). There were no significant differences on IL-6,TNF-α and IL-10 concentrations in drug-alone groups compared with control group (P > 0.05). Conclusion Remifentanyl or fentanyl alone has no effects on IL-6, TNF-α and IL-10 production, but could attenuate LPS-induced IL-6,TNF-α and IL-10 production in human whole blood. Remifentanyl and fentanyl could inhibit the expressions of IL-6, TNF-α and IL-10 induced by LPS.
Similar content being viewed by others
References
Vallejo R, de Leon-Casasola O, Benyamin R (2004) Opioid therapy and immunosuppression: a review. Am J Ther 11:354–365. doi:10.1097/01.mjt.0000132250.95650.85
Peterson PK, Molitor TW, Chao CC (1998) The opioid-cytokine connection. J Neuroimmunol 83:63–69. doi:10.1016/S0165-5728(97)00222-1
Bozza FA, Salluh JI, Japiassu AM et al (2007) Cytokine profiles as markers of disease severity in sepsis: a multiplex analysis. Crit Care 11:R49. doi:10.1186/cc5783
Opal SM (2007) The host response to endotoxin, antilipopolysaccharide strategies, and the management of severe sepsis. Int J Med Microbiol 297:365–377. doi:10.1016/j.ijmm.2007.03.006
Beutler B, Rietschel ET (2003) Innate immune sensing and its roots: the story of endotoxin. Nat Rev Immunol 3:169–176. doi:10.1038/nri1004
Mason P (2002) Remifentanil. Intensive Crit Care Nurs 18:355–357. doi:10.1016/S0964-3397(02)00087-3
Rao Y, Wang YL, Li JG et al (2004) Effects of morphine and fentanyl on tumor necrosis factor-alpha and interleukin-6 concentrations in human whole blood in vitro. Chin Med J (Engl) 117:303–304
Sacerdote P, Gaspani L, Rossoni G et al (2001) Effect of the opioid remifentanil on cellular immune response in the rat. Int Immunopharmacol 1:713–719. doi:10.1016/S1567-5769(01)00005-4
Kawasaki T, Ogata M, Kawasaki C et al (1999) Ketamine suppresses proinflammatory cytokine production in human whole blood in vitro. Anesth Analg 89:665–669. doi:10.1097/00000539-199909000-00024
DeForge LE, Kenney JS, Jones ML et al (1992) Biphasic production of IL-8 in lipopolysaccharide -stimulated human whole blood. Separation of LPS- and cytokine-stimulated components using anti-tumor necrosis factor and anti-IL-1 antibodies. J Immunol 148:2133–2141
Sheeran P, Hall GM (1997) Cytokines in anaesthesia. Br J Anaesth 78:201–209
Moore CM, Desborough JP, Powell H et al (1994) Effects of extradural anaesthesia on IL-6 and acute phase response to surgery. Br J Anaesth 72:272–279. doi:10.1093/bja/72.3.272
Conti P, Kempuraj D, Kandere K et al (2003) IL-10, an inflammatory/inhibitory cytokine, but not always. Immunol Lett 86:123–129. doi:10.1016/S0165-2478(03)00002-6
Lang R, Patel D, Morris JJ et al (2002) Shaping gene expression in activated and resting primary macrophages by IL-10. J Immunol 169:2253–2263
Cavaillon JM, Annane D (2006) Compartmentalization of the inflammatory response in sepsis and SIRS. J Endotoxin Res 12:151–170. doi:10.1179/096805106X102246
Zanotti S, Kumar A, Kumar A (2002) Cytokine modulation in sepsis and septic shock. Expert Opin Investig Drugs 11:1061–1075. doi:10.1517/13543784.11.8.1061
Wei G, Moss J, Yuan CS (2003) Opioid-induced immunosuppression: is it centrally mediated or peripherally mediated? Biochem Pharmacol 65:1761–1766
Xin-Min W, Tie-Hu Y, Yun Y et al (2003) Effeacy and safety of China-made remifentanil. Chin J Anesthesiol 23:245–248
Rosow CE (1999) An overview of remifentanil. Anesth Analg 89:451–453. doi:10.1097/00000539-199910001-00001
Cortinez LI, Munoz HR, Dela Fuente R et al (2005) Target-controlled infusion of remifentanil or fentanyl during extra-corporeal shock-wave lithotripsy. Eur J Anaesthesiol 22:56–61. doi:10.1017/S0265021505000128
Acknowledgement
We thank Yichang Renfu Corporation (Yichang, China) for their excellent assistance in fund support.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Wu, Y., Wang, Y. & Zhan, J. Effects of remifentanyl and fentanyl on LPS-induced cytokine release in human whole blood in vitro. Mol Biol Rep 36, 1113–1117 (2009). https://doi.org/10.1007/s11033-008-9286-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11033-008-9286-4